ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Inks Four-Year Proteome Resear
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Mersana Ends 2022 With Third Big Pharma
ScripH. Lundbeck A/S is the latest pharma company to benefit from the upsurge in interest in hitherto unsuccessful Alzheimer's disease assets driven by the recent controversial US approval of Biogen, Inc
Generics BulletinAlvogen, Inc. and sister company Alvotech have announced a donation of $100,000to UNICEF to help get COVID-19 vaccines to over 90 low-and-middle-income countries. Alvogen revealed that it had signe